CD248 and neoplasm: For group 1 and 2, uptake in TEM-1 positive tumor was 10.8% ± 1.55 IA/g 4 h after injection and remained consistently high even 3 days after injection (15.8% ± 1.9 IA/g), demonstrating retention of TEM-1 targeted antibody.